Wilmer Cutler Pickering Hale and DLA Piper advised Akamai Technologies, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers....
Akamai’s $1.725 Billion Convertible Senior Notes Offering
Canadian Pacific’s $1.2 Billion Senior Notes Offering
Sullivan & Cromwell advised Canadian Pacific, while Davis Polk & Wardwell advised the joint book-running managers and representatives of the underwriters in the offering. Canadian Pacific...
MBX Biosciences’ $187.7 Million IPO
Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
Tradeweb Markets’ $785 Million Acquisition of Institutional Cash Distributors
Fried, Frank, Harris, Shriver & Jacobson acted as counsel to Tradeweb Markets Inc., while Kirkland & Ellis advised Parthenon Capital Partners and ICD on the deal....
Stoke Therapeutics’ $125 Million Upsized Common Stock Offering
Fenwick & West advised Stoke Therapeutics on the offering, Wilson Sonsini Goodrich & Rosati advised Stoke on IP matters and Davis Polk & Wardwell advised the...
Smith Douglas Homes’ $186 Million IPO
Latham & Watkins represented Smith Douglas Homes Corp. in the offering, and Davis Polk & Wardwell advised the joint book-running managers. Smith Douglas Homes Corp. (NYSE:...
Rapid7’s $260 Million Convertible Notes Offering
Davis Polk & Wardwell advised Rapid7, Inc. on the offering. Rapid7, Inc. (Nasdaq: RPD) (“Rapid”) announced it has completed its Rule 144A offering of $260 million aggregate...
Tetra Tech’s $575 Million Convertible Notes Offering
Davis Polk & Wardwell represented the initial purchasers in the offering. Tetra Tech, Inc. announced its Rule 144A offering of $575 million aggregate principal amount of its 2.25%...
Johnson & Johnson’s Split-Off of Kenvue Inc.
Davis Polk & Wardwell advised the dealer managers on the transaction. Johnson & Johnson (NYSE: JNJ) announced the final exchange ratio for its split-off exchange offer...
TScan Therapeutics’ $140.6 Million Stock and Pre-funded Warrants Offering
Davis Polk advised Morgan Stanley & Co. LLC and Wedbush Securities Inc. on the offering. TScan Therapeutics, a biopharmaceutical company, has announced a $140.6 million SEC-registered common...
LyondellBasell’s $500 Million Inaugural Green Bond Offering
Gibson Dunn & Crutcher advised LyondellBasell on the deal, while Davis Polk advised Morgan Stanley & Co. LLC and ING Financial Markets LLC. LyondellBasell (NYSE: LYB), a...
Kenvue’s $4.37 Billion Initial Public Offering
Cravath advised Kenvue, and Davis Polk advised the representatives of the underwriters involved in the IPO. Kenvue Inc. announced its $4.37 billion upsized initial public offering of...